Describing the plasma concentration-time profile (pharmacokinetics, PK) and understanding the quantitative link to therapeutic response (pharmacodynamics, PD) of a drug is paramount for selection of the optimal dosage amount and frequency to treat patients and minimize unwanted adverse events.

Population pharmacokinetic/pharmacodynamic (PK-PD) modelling






















































































Group leader

Group Leader

Trine Meldgaard Lund 
Associate Professor

Phone +45 3533 6340

Group members

Name Title Phone E-mail
Ida Hagen Storgaard PhD Fellow +4529287387 E-mail
Trine Meldgaard Lund Associate Professor +4535336340 E-mail